How Can Pharma Seek To Discuss Gender Diversity?
Communications Ought To Be Both Accessible And Inclusive
Executive Summary
As gender-neutral language becomes more widely used throughout the business community, the pharmaceutical industry must confront how it approaches the matter of gendered language in healthcare communications.
You may also be interested in...
Exec Chat: Abbott Invests In Outreach To Underrepresented Populations
Jennifer Jones-McMeans, Divisional Vice President of Global Clinical Affairs at Abbott’s vascular device business, talked to Medtech Insight about her company’s ongoing efforts to diversify patient enrollment in clinical trials by communicating more effectively and compassionately with people in traditionally underrepresented demographic groups.
Sanofi Tries To ‘Bring More Of The Outside In’ For Diversity Efforts
The company is focusing first on gender parity as it navigates around tricky legal frameworks on collecting demographic data.
Off-Patent Personnel Moves In 2023 Reflect Growing Interest In Innovator Space
Executive changes at both Viatris and Teva in 2023 saw the companies shift their focus towards the innovator industry. Plus, trade groups saw some significant personnel shakeups, Alvotech expressed hope that new hires would help to resolve manufacturing approval issues, Biocon made changes to its management structure, and more.